Luhan Pharmachem Co., Ltd.

Luhan pharmachem Co., Ltd. supplies Ansamitocin bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Ansamitocin is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.

We supply from small R&D to commercial Quantity.

What is Ansamitocin?

Ansamitocin P-3 is a maytansine analog which displays potent cytotoxicity against the human solid tumor cell lines A-549 and HT-29. It shares the same binding site as rhizoxin and phomopsin A on porcine brain tubulin. Maytansine and its analogs cause extensive disassembly of the microtubule and totally prevent tubulin spiralization. Ansamitocin P-3 is a fungal metabolite with antimitotic, antimitotic activity. Ansamitocin P-3 binds to tubulin and inhibits vinblastine-induced spiral formation.

Disclaimer:

Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.